Administration of Zidovudine During Late Pregnancy and Delivery to Prevent Perinatal HIV Transmission - Thailand,1996 - 1998
Abstract
References
World Health Organization.Global AIDS surveillance--Part I. Weekly Epidemiology Record 1997;72:357-60.
Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl I Med 1996;335:1621-9.
CDC. Recommendations ofthe U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994; 43(No. RR-11).
Shaffer N, Bhiraleus P, Chinayon P, et al.High viral load predicts perinatal HIV-I subtype E transmission, Bangkok, Thailand [abstract]. Xith International Conference on AIDS, Vancouver. Canada, July 1996.
Bertolli J, St. Louis ME, Simonds RJ, et alimating the timing of mother-to-child transmission of human immunodeficiency virus in a breastfeeding population in Kinshasa, Zaire. J Infect Dis 1996;174:722-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 199 Weekly Epidemiological Surveillance Report
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Responsibility and Copyright
1. Author Responsibility and Editorial Disagreement
The content and data in all articles published in WESR are the direct opinions and responsibility of the article authors, and the Journal's Editorial Board is not necessarily in agreement with, or jointly responsible for, them.
2. Copyright and Referencing
All articles, data, content, figures, etc., published in WESR are considered the copyright of the academic journal. If any individual or entity wishes to disseminate all or any part of the published material, appropriate citation of the article is required.
